KURA – Kura Oncology, Inc.
Kura Oncology, Inc.KURA
$6.02Name : Kura Oncology, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $521,179,712.00
EPSttm : -2.09
Kura Oncology, Inc.
$6.02
0.50%$0.03Float Short %
10.22
Margin Of Safety %
-27
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.02
EPS Last/This Y
-0.04
EPS This/Next Y
0.11
Price
6.02
Target Price
25.92
Analyst Recom
1.33
Performance Q
-7.24
Relative Volume
0.92
Beta
0.4
Ticker: KURA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | KURA | 5.86 | 0.80 | 7.14 | 8114 |
| 2025-07-07 | KURA | 5.68 | 0.81 | 4.59 | 8171 |
| 2025-07-08 | KURA | 5.81 | 0.86 | 0.04 | 8379 |
| 2025-07-09 | KURA | 6.15 | 0.83 | 0.36 | 8538 |
| 2025-07-10 | KURA | 6.36 | 0.83 | 0.00 | 8542 |
| 2025-07-11 | KURA | 6.28 | 0.83 | 0.00 | 8543 |
| 2025-07-14 | KURA | 6.34 | 0.82 | 0.00 | 8565 |
| 2025-07-15 | KURA | 6.13 | 0.82 | 0.00 | 8576 |
| 2025-07-16 | KURA | 6.38 | 0.81 | 0.04 | 8630 |
| 2025-07-17 | KURA | 6.61 | 0.80 | 0.00 | 8680 |
| 2025-07-18 | KURA | 6.36 | 0.82 | 0.11 | 8596 |
| 2025-07-21 | KURA | 6.45 | 0.05 | 0.00 | 1789 |
| 2025-07-22 | KURA | 6.66 | 0.05 | 0.00 | 1803 |
| 2025-07-23 | KURA | 6.43 | 0.05 | 0.00 | 1879 |
| 2025-07-24 | KURA | 6.46 | 0.05 | 0.00 | 1925 |
| 2025-07-25 | KURA | 6.22 | 0.05 | 0.00 | 2051 |
| 2025-07-28 | KURA | 6.2 | 0.04 | 0.02 | 2097 |
| 2025-07-29 | KURA | 6.36 | 0.04 | 0.50 | 2225 |
| 2025-07-30 | KURA | 6.3 | 0.04 | 0.00 | 2225 |
| 2025-07-31 | KURA | 6.05 | 0.07 | 13.00 | 2292 |
| 2025-08-01 | KURA | 6.01 | 0.09 | 0.03 | 2318 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | KURA | 5.86 | 30.9 | - | -2.06 |
| 2025-07-07 | KURA | 5.68 | 30.9 | - | -2.06 |
| 2025-07-08 | KURA | 5.81 | 30.9 | - | -2.06 |
| 2025-07-09 | KURA | 6.16 | 30.9 | - | -2.06 |
| 2025-07-10 | KURA | 6.36 | 30.9 | - | -2.06 |
| 2025-07-11 | KURA | 6.28 | 30.9 | - | -2.06 |
| 2025-07-14 | KURA | 6.35 | 30.9 | - | -2.06 |
| 2025-07-15 | KURA | 6.13 | 30.9 | - | -2.06 |
| 2025-07-16 | KURA | 6.38 | 30.9 | - | -2.06 |
| 2025-07-17 | KURA | 6.60 | 30.9 | - | -2.06 |
| 2025-07-18 | KURA | 6.36 | 30.9 | - | -2.06 |
| 2025-07-21 | KURA | 6.46 | 30.9 | - | -2.06 |
| 2025-07-22 | KURA | 6.67 | 30.9 | - | -2.06 |
| 2025-07-23 | KURA | 6.44 | 30.9 | - | -2.06 |
| 2025-07-24 | KURA | 6.47 | 30.9 | - | -2.06 |
| 2025-07-25 | KURA | 6.23 | 30.9 | - | -2.06 |
| 2025-07-28 | KURA | 6.22 | 30.9 | - | -2.06 |
| 2025-07-29 | KURA | 6.37 | 30.9 | - | -2.06 |
| 2025-07-30 | KURA | 6.30 | 30.9 | - | -2.06 |
| 2025-07-31 | KURA | 6.05 | 30.9 | - | -2.06 |
| 2025-08-01 | KURA | 6.02 | 30.9 | - | -2.06 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | KURA | -1.12 | 3.19 | 9.60 |
| 2025-07-07 | KURA | -1.12 | 3.14 | 9.60 |
| 2025-07-08 | KURA | -1.12 | 3.14 | 9.60 |
| 2025-07-09 | KURA | -1.12 | 3.14 | 9.60 |
| 2025-07-10 | KURA | -1.12 | 3.14 | 9.60 |
| 2025-07-11 | KURA | -1.12 | 3.14 | 9.55 |
| 2025-07-14 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-15 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-16 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-17 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-18 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-21 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-22 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-23 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-24 | KURA | -1.12 | 3.27 | 9.55 |
| 2025-07-25 | KURA | -1.12 | 3.27 | 10.22 |
| 2025-07-28 | KURA | -1.12 | 3.35 | 10.22 |
| 2025-07-29 | KURA | -0.60 | 3.35 | 10.22 |
| 2025-07-30 | KURA | -0.60 | 3.35 | 10.22 |
| 2025-07-31 | KURA | -0.60 | 3.35 | 10.22 |
| 2025-08-01 | KURA | -0.60 | 3.35 | 10.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.66
Avg. EPS Est. Current Quarter
-0.41
Avg. EPS Est. Next Quarter
-0.64
Insider Transactions
-0.6
Institutional Transactions
3.35
Beta
0.4
Average Sales Estimate Current Quarter
64
Average Sales Estimate Next Quarter
18
Fair Value
4.37
Quality Score
27
Growth Score
24
Sentiment Score
4
Actual DrawDown %
86
Max Drawdown 5-Year %
-86.7
Target Price
25.92
P/E
Forward P/E
PEG
P/S
7.67
P/B
1.33
P/Free Cash Flow
4.71
EPS
-2.09
Average EPS Est. Cur. Y
-2.06
EPS Next Y. (Est.)
-1.95
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-267.52
Relative Volume
0.92
Return on Equity vs Sector %
-73.6
Return on Equity vs Industry %
-55
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Kura Oncology, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 192
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading